肝硬化妊娠发生率上升且与不良母儿结局相关
基于美国全国住院样本2012至2016年1857万余次分娩数据,肝硬化妊娠从2007年2.5/10万升至2016年6.5/10万(P=0.01)。校正分析显示肝硬化与高血压并发症、产后出血和早产风险升高相关,母胎死亡少见。作者认为需对肝硬化年轻女性进行生殖咨询和多学科妊娠管理。
要点
- 肝硬化妊娠发生率从2007年2.5/10万升至2016年6.5/10万(P=0.01)。
- 肝硬化与高血压并发症、产后出血和早产风险升高相关(校正后OR 2.0至4.9)。
- 肝硬化与孕产妇死亡存在统计学关联,但发生率≤1%。
核心结论
- 在美国种族多样的人群中,肝硬化妊娠在过去十年间增加了一倍以上,肝硬化与多种不良事件风险升高相关,但母胎死亡不常见。
研究设计与样本
- 基于美国全国住院样本出院数据的回顾性人群研究,纳入2012至2016年18,573,000次分娩,其中肝硬化895例、非肝硬化慢性肝病119,875例、无慢性肝病18,452,230例。
- 采用logistic回归校正年龄、种族、多胎妊娠、保险状态和孕前代谢合并症。
主要发现
- 肝硬化妊娠从2007年2.5/100,000升至2016年6.5/100,000(P=0.01)。
- 校正分析中,肝硬化与高血压并发症相关:vs 无慢性肝病 OR 4.9(95%CI 3.3-7.4),vs 非肝硬化慢性肝病 OR 4.4(95%CI 3.0-6.7)。
- 肝硬化与产后出血相关:vs 无慢性肝病 OR 2.8(95%CI 1.6-4.8),vs 非肝硬化慢性肝病 OR 2.0(95%CI 1.2-3.5)。
- 肝硬化与早产相关:vs 无慢性肝病 OR 3.1(95%CI 1.9-4.9),vs 非肝硬化慢性肝病 OR 2.0(95%CI 1.3-3.3),P≤0.01。
- 肝硬化与孕产妇死亡存在统计学关联,但发生率≤1%。
临床怎么用
- 作者认为这些数据强调需要对肝硬化年轻女性进行生殖咨询和多学科妊娠管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cirrhosis incidence in pregnancies from outside the United States (US) is rising, although contemporary data including maternal and perinatal outcomes within the United States are lacking. METHODS: Using discharge data from the racially diverse US National Inpatient Sample, temporal trends of cirrhosis in pregnancies were compared with noncirrhotic chronic liver disease (CLD) or no CLD. Outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (preeclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. Logistic regression was adjusted for age, race, multiple gestation, insurance status, and prepregnancy metabolic comorbidities. RESULTS: Among 18,573,000 deliveries from 2012 to 2016, 895 had cirrhosis, 119,875 had noncirrhotic CLD, and 18,452,230 had no CLD. Pregnancies with cirrhosis increased from 2.5/100,000 in 2007 to 6.5/100,000 in 2016 (P = 0.01). On adjusted analysis, cirrhosis was associated with hypertensive complications (vs no CLD, OR 4.9, 95% confidence intervals [CI] 3.3-7.4; vs noncirrhotic CLD, OR 4.4, 95% CI 3.0-6.7), postpartum hemorrhage (vs no CLD, OR 2.8, 95% CI 1.6-4.8; vs noncirrhotic CLD, OR 2.0, 95% CI 1.2-3.5), and preterm birth (vs no CLD, OR 3.1, 95% CI 1.9-4.9; vs noncirrhotic CLD, OR 2.0, 95% CI 1.3-3.3, P ≤ 0.01). Cirrhosis was statistically associated with maternal mortality, although rarely occurred (≤ 1%). DISCUSSION: In this racially diverse, US population-based study, pregnancies with cirrhosis more than doubled over the past decade. Cirrhosis conferred an increased risk of several adverse events, although maternal and perinatal mortality was uncommon. These data underscore the need for reproductive counseling and multidisciplinary pregnancy management in young women with cirrhosis.
引用
- Huang AC, Grab J, Flemming JA, et al. Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes. Am J Gastroenterol. 2022. PMID: 34928866. doi:10.14309/ajg.0000000000001590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。